| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5603938 High molecular weight surface proteins of non-typeable haemophilus |
| 02/18/1997 | US5603933 Peptides including sequence serine-arginine-arginine-serine; capable of binding to hiv glycoprotein |
| 02/18/1997 | US5603932 Receptor of the minor human rhinovirus receptor group |
| 02/13/1997 | WO1997005468A2 A confirmatory serodiagnostic assay for infectious diseases |
| 02/13/1997 | WO1997005267A2 Mucosal delivery of polynucleotides |
| 02/13/1997 | WO1997005262A1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
| 02/13/1997 | WO1997005253A2 Transketolase-related protein |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005168A1 The h-y antigen |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1997004807A1 Methods for treatment of allergic asthma |
| 02/13/1997 | WO1997004806A1 Remedy for neurological disorders |
| 02/13/1997 | WO1997004805A1 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators |
| 02/13/1997 | WO1997004804A1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 02/13/1997 | WO1997004803A1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004801A1 Stabile isotonic lyophilized protein formulation |
| 02/13/1997 | WO1997004798A1 H-y derived epitopes and uses therefor |
| 02/13/1997 | WO1996002572A3 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/13/1997 | CA2745743A1 Stabile isotonic lyophilized protein formulation |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | CA2227871A1 Mucosal delivery of polynucleotides |
| 02/13/1997 | CA2226624A1 Methods for treatment of allergic asthma |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224894A1 The h-y antigen |
| 02/12/1997 | EP0757722A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO) |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757697A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection |
| 02/12/1997 | EP0757696A1 Human sperm diagnostic |
| 02/12/1997 | EP0757694A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals |
| 02/12/1997 | EP0757689A1 Porphocyanine and cnc-expanded porphyrins |
| 02/12/1997 | EP0757559A1 Composition for delivery of toxic radioisotopes to the cell nucleus and use |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0757556A1 $i(BORRELIA BURGDORFERI) BACTERIN |
| 02/12/1997 | EP0589933B1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | CN1142855A Humanized antibodies and uses thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142775A Preparation and use of immunoconjugates |
| 02/12/1997 | CN1142774A Vibrio cholerae 01(CVD111) and Non-01(CVD112 and CVD112RM) serogroup vaccine strains and methods of making same |
| 02/12/1997 | CN1142773A Probiotic for control of salmonella |
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/12/1997 | CA2183020A1 Activated immunoglobulin |
| 02/12/1997 | CA2183012A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602033 Coccidiosis vaccine |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602022 Production of infectious bursal disease virus in mammalian cell line |
| 02/11/1997 | US5602005 Antigen remains associated with primate sperm after acrosome reaction |
| 02/11/1997 | US5602003 N-acetylglucosaminyltransferase V gene |
| 02/11/1997 | US5601993 Detecting colon cancer and latent colon cancer by measuring concentrations of primary and secondary bile acids in feces by elisa, calculating ratio |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601974 Method of detecting viral infection in vaccinated animals |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601826 A linear tetanus-toxin-specific epitope |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601823 Avian antitoxins to clostridium difficle toxin A |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |
| 02/11/1997 | US5601816 Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production of same |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004098A2 MODIFIED HUMAN CHORIONIC (β-hCG) PROTEINS AND THEIR MEDICAL USE |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003995A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1996040926A3 Detection of cryptosporidium parvum |
| 02/06/1997 | WO1996040766A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 02/06/1997 | CA2227592A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2223914A1 Compositions and methods for catalyzing hydrolysis of hiv gp120 |
| 02/05/1997 | EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 02/05/1997 | EP0756629A1 Pharmaceutical formulations for treating japanese cedar pollen allergy |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756604A1 Melanoma antigens |
| 02/05/1997 | EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells |
| 02/05/1997 | EP0662080B1 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 02/05/1997 | CN1142231A Abundant extracellular products and methods for production and use of same |
| 02/05/1997 | CN1142189A Platelet-special chimeric immunoglobulin and methods of use thereof |